Revatio (sildenafil citrate) - Important Safety Information from Pfizer Healthcare Ireland as approved by the Irish Medicines Board
04 October 2011
Important Safety Information relating to increased risk of mortality in paediatric patients with pulmonary arterial hypertension with the use of higher than recommended doses of Revatio (sildenafil citrate).
Pfizer Revatio DHPC 04.09.11.pdf